Sections

Services

Information

US United States

Transparency and medicine

Articles (1 - 20 of 22)

The current debate obscures the much larger question of why doctors need to receive “tea and biscuits” from pharmaceutical companies at all. Yortw/Flickr

Forget tea and biscuits, why should doctors get any gifts from pharma companies?

The Australian Medical Association (AMA) and medical specialist groups are currently debating public disclosure of gifts received by doctors from pharmaceutical companies. The bone of contention is how…
Tamiflu was stockpiled amid flu outbreaks and scares. Rui Vieira/PA

Tamiflu cost us £424m yet we still don’t know much about it

Are you worried about how decisions involving public money are made? You should be. Last week, the National Audit Office disclosed that the Department of Health spent £424 million on the anti-flu drug…
Reform of medical regulations has become a hot potato being passed from one agency to another. eltpics/Flickr

Consumers lose out as TGA reform turns into a hot potato

Two bills in the national parliament provide a snapshot of our health regulatory system, and just like a smoker’s lungs, it’s not a pretty picture. The bills show that we’re slow in fixing regulatory incapacity…
Roche has refused to share clinical trial data for Tamiflu, which is used to relieve symptoms and reduce complications of influenza. AAP/Joe Castro

Remove industry bias from clinical trials before it’s too late

A study published today shows that clinical trials with industry sponsorship report greater benefits and fewer harmful side effects. In the discussion, the authors note that most reviews and guidelines…
Post-marketing studies are often used as ploys to get doctors in the habit of prescribing expensive new medicines. Flickr / Nestle

How Big Pharma opens the market to new expensive drugs

New medicines are often marketed on the basis of clinical trials of limited size and duration. So clinical studies of a medicine after it has reached the market (post-marketing studies) can be a useful…
A fundamental change in the relationship between industry and medical professionals is needed. flickr/buddawiggi

Have we reached the limit of effectiveness of self-regulation and codes of ethics?

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Medicines Australia’s code of conduct governs the promotion of prescription drugs and the relationship of industry to health professionals. LadyofProcrastination/Wikimedia Commons

Consumer input in Medicines Australia’s code of conduct review

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Guidelines help doctors decide on the best way to treat patients. Jocelyn Augustino/FEMA News Photo

Conflicts of interest in guideline development: the NHMRC responds

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
The business and medical worlds are replete with examples of unethical conduct when it comes to accepting and giving gifts. Li'l Wolf

Ethics of accepting suppliers' gifts in the business v medical world

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Most surveyed patients said they’d have more confidence in their doctor’s decisions with full disclosure of competing interests. AAP Image/Alan Porritt

Reaching full and open disclosure for universities, medical schools and doctors

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
The obligation to tell patients about medical mistakes is clear but we don’t know whether it’s complied with. hang_in_there/Flickr

Open disclosure: why doctors should be honest about errors

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
AAP/Tracey Nearmy

Why data from published trials should be made public

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
SKB knew eight adolescents self-harmed or reported emergent suicidal ideas compared to only one in the placebo group but hid this. Michael Valli

Insight into how pharma manipulates research evidence: a case study

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Vioxx is the quintessential story of what can go wrong when a big pharmaceutical company exerts influence over the evidence base. AAP

Pharma’s influence over published clinical evidence

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Acknowledging that things don’t always go right, and trying to figure out what went wrong are hallmarks of a transparent and mature profession. AAP

Clearing the air: why more retractions are good for science

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Conflict of interest management depends on the existence of a critical culture that recognises the issues. Waldo Jaquith

Don’t show me the money: the dangers of non-financial conflicts

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
New therapies that haven’t yet been clinically proven may still be used ethically under certain circumstances. Juraj Kubica

Eminence or evidence? The ethics of using untested treatments

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Perceptions of conflict can be just as damaging to community confidence as conflicts themselves. 401K/Flickr

Show and tell: conflicts of interest undeclared for clinical guidelines

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…

Top contributors

More